CVS tops quarterly estimates, reaffirms profit outlook as turnaround plan takes effect
A pedestrian walks by a CVS store in Greenbrae, California, on July 31, 2025. Justin Sullivan | Getty Images CVS
Read More
Earnings
Gucci-owner Kering jumps 12% as new CEO maps revival, sales beats estimates
Customers shop at a GUCCI luxury store in Shanghai, China. Cfoto | Future Publishing | Getty Images Kering said it
Read More
SoftBank shares surge 10% after telecom unit lifts outlook, Arm strength bolsters AI
Shares of SoftBank Group Corp jumped over 10% after its telecom arm, SoftBank Corp, raised its full-year profit outlook, while
Read More
South Korea’s largest defense firm Hanwha Aerospace slumps 6% as revenue, pre-tax profit
A large screen displays images of Combat Unmanned Surface Vessels (USV) at the Hanwha exhibition stand during the Security Equipment
Read More
Here are 3 major moments that drove the stock market last week
A massive market snapback on Friday couldn’t erase all of the week’s damage. After several days of selling, the tech
Read More
Amazon cloud unit beats on revenue and profit as parent company ramps up AI spending
Amazon Web Services CEO Matt Garman delivers a keynote address at the AWS re:Invent conference in Las Vegas on Dec.
Read More
We’re increasing our price target on Bristol Myers after earnings and guidance top forecasts
Bristol Myers Squibb on Thursday delivered strong fourth quarter results — and better yet, issued a 2026 forecast that was
Read More
Alphabet’s strong quarter eases fears about the search giant’s sky-high spending
Alphabet reported fantastic fourth-quarter results on Wednesday, proof that its eye-popping spending on artificial intelligence is accelerating growth across all
Read More
Qualcomm stock sinks as memory shortage drags on forecast
President and CEO of Qualcomm Cristiano Amon delivers a speech at the Web Summit at Parque das Nacoes in Lisbon,
Read More
We’re raising our price target on Eli Lilly as the GLP-1 leader delivers a huge beat
Eli Lilly ‘s fourth-quarter results blew past Wall Street estimates on Wednesday, as key GLP-1 drugs, Mounjaro for diabetes and
Read More